Recovery.com Announces New Advertiser Certification Partnership with LegitScript
Recovery.com reinforces its commitment to advertiser quality with enhanced verification aligned with industry standards MADISON, Wis., July 14, 2025 /PRNewswire/...
Addiction
Announcing EX Program Go from Truth Initiative: A Scalable Digital Tobacco Cessation Solution for Small to Mid-Sized Employers
WASHINGTON, July 10, 2025 /PRNewswire/ -- The team behind EX Program, the leading digital tobacco cessation solution developed by Truth...
Hansei Solutions Welcomes Health Care Revenue Cycle Management Leader Nick Rogers as COO
Appointment strengthens operational growth and tech-driven innovation in behavioral health FRANKLIN, Tenn., July 10, 2025 /PRNewswire/ -- Hansei Solutions, the...
Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
Application Update Based on Extensive Review of DataGLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:...
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
Appointment highlights DIMERx’s next phase of growth as it advances non-addictive pain therapeutics with support from the NIH HEAL InitiativeSAN...
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium
ART26.12, a Novel FABP5 Inhibitor, Demonstrates Sustained Analgesic Effects Without ToleranceSOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Artelo...
New Podcast “Spreading the Good BUZZ” Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
Through Hope and Community in Recovery, Sober.Buzz along with @SoberBuzzToken on Instagram are Impacting and Changing Lives Around the World...
Hazelden Betty Ford Mourns the Loss of Addiction Advocate Bill Moyers
Center City, Minnesota--(Newsfile Corp. - June 27, 2025) - The Hazelden Betty Ford Foundation expresses deep sorrow at the passing...
Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply
Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement...
DIMERx Awarded Up to $15M by NIDA Under NIH HEAL Initiative® to Advance DMX-101 as a Non-Addictive Oral Therapy for Chronic Pain
The Award Highlights the Promise of Exclusively Targeting Peripheral Opioid Receptors to Treat Chronic Pain Without the Risk of Addiction...
As Sober.Buzz Community Explodes Its Growth Globally it is Announcing “Spreading the Good BUZZ” Podcast Hosted by Josh Case Debuting July 7th
Sober.Buzz's Online Store that includes the Exclusive Inspirational Collection by Heidi Case has Launched. Additionally, the much-anticipated Public Sale of...
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")...
Project 55 Launches Free Mental Health First Responder Training for Public Use
Evidence-informed course equips non-professionals to respond to mental health crises with practical, scalable skills Project 55 Logo LADERA RANCH, Calif.,...
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
Engages with Cytel’s Machine Learning Technology on Data Analysis and Phase 3 Trial DesignGLEN ALLEN, Va., June 11, 2025 (GLOBE...
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
Improvement in depression scores, response and remission were all found to be comparable with standard Deep TMS in non-inferiority trialBURLINGTON,...
Chestnut Health Systems Launches The Catalyst – A Podcast and Newsletter Advancing Recovery Science
BLOOMINGTON, Ill., June 10, 2025 /PRNewswire/ -- Chestnut Health Systems™ announced the launch of The Catalyst, a weekly podcast and...
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
Deep TMS Takes Center Stage with Compelling ResearchBURLINGTON, Mass. and JERUSALEM, June 10, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ...
Ambio Life Sciences Launches World’s First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized dosing and therapeutic support for...
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to raise awareness and expand access to...
TOLREMO therapeutics Announces TT125-802 is the First CBP/p300 Bromodomain Inhibitor to Show Clinical Activity in Solid Tumors
- Deep and durable responses in drug-resistant KRAS-G12C- and EGFR-mutant NSCLC - Best-in-class safety profile highlights potential for development in...